A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.
The best Bull and Bear pitches based on recency and number of recommendations.
What a staggeringly STAGGERINGLY bad company! The numbers are absolutely obstrusive. These guys could write a book on how to lose money and it would be a best seller. Cytori has lost a whopping 52M in the last 2 years and is sitting on less than 30M… More
Read the most recent pitches from players about CYTX.DL.
Find the members with the highest scoring picks in CYTX.DL.
See what the Wall Street professionals think, according to their public statements and filings.